Laxido (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that stays within the intestinal lumen. It binds water osmotically, raising the fluid volume of the stool. This softens the fecal mass and stimulates peristalsis, facilitating spontaneous bowel movements without being absorbed into the bloodstream.

The appropriate dose of Laxido is individualized and set by a qualified prescriber based on the patient’s age, weight, severity of constipation, and response to therapy. Dosing instructions are provided on the product label and should be followed exactly as directed by the healthcare professional.

Safety data for Laxido in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using this medication.

To order Laxido, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Laxido (macrogol 3350) works by osmotic water retention rather than stimulating intestinal muscles, resulting in a gentler, more physiological effect and a lower incidence of cramping. It is also preferred over bulk‑forming agents for patients who need rapid stool softening.

Laxido should be stored at ambient temperature, below 25 °C, in its original container. Keep the solution away from moisture, direct sunlight and extreme heat. Ensure the bottle is tightly closed after each use to maintain product stability.

Laxido is supplied as an oral solution. The prescribed volume is measured with a calibrated dosing device and taken orally, usually once daily or as directed by the prescriber. It can be mixed with a small amount of water or a clear fluid if preferred, but should be consumed promptly.

Serious risks, although rare, include severe electrolyte imbalance, marked dehydration, and allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience symptoms like rapid heartbeat, muscle weakness, severe abdominal pain, or signs of an allergic response.

Laxido should be avoided in individuals with known hypersensitivity to macrogol or any of its excipients, in patients with intestinal obstruction, perforation, or severe inflammatory bowel disease, and in those for whom electrolyte disturbances would pose a significant risk. Consultation with a healthcare professional is essential before use.